2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid
C65H70F2N16O12 — CID 166612011
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid
2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid (PubChem CID 166612011) has the molecular formula C65H70F2N16O12 and a molecular weight of 1305.37 g/mol. Its IUPAC name is 2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid.
Molecular Properties
| Compound Name | 2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid |
|---|---|
| PubChem CID | 166612011 |
| Molecular Formula | C65H70F2N16O12 |
| Molecular Weight | 1305.37 g/mol |
| Exact Mass | 1304.53 |
| IUPAC Name | 2-[(10R,13S,16S,19S,22S,25S,31S,34S)-34-carbamoyl-13,16-bis[(5-fluoro-1H-indol-3-yl)methyl]-22-(1H-imidazol-5-ylmethyl)-25-[(4-methoxyphenyl)methyl]-10,31-dimethyl-8,11,14,17,20,23,26,32-octaoxo-2,3,4,9,12,15,18,21,24,27,33-undecazatetracyclo[34.2.2.12,5.027,31]hentetraconta-1(39),3,5(41),36(40),37-pentaen-19-yl]acetic acid |
| SMILES | COc1ccc(C[C@@H]2NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@H](Cc3c[nH]c4ccc(F)cc34)NC(=O)[C@@H](C)NC(=O)CCc3cn(nn3)-c3ccc(cc3)C[C@@H](C(N)=O)NC(=O)[C@]3(C)CCCN3C2=O)cc1 |
| InChI | InChI=1S/C65H70F2N16O12/c1-34-58(88)74-50(23-37-29-70-47-16-9-39(66)25-45(37)47)59(89)75-51(24-38-30-71-48-17-10-40(67)26-46(38)48)60(90)77-53(28-56(85)86)62(92)76-52(27-42-31-69-33-72-42)61(91)78-54(22-36-7-14-44(95-3)15-8-36)63(93)82-20-4-19-65(82,2)64(94)79-49(57(68)87)21-35-5-12-43(13-6-35)83-32-41(80-81-83)11-18-55(84)73-34/h5-10,12-17,25-26,29-34,49-54,70-71H,4,11,18-24,27-28H2,1-3H3,(H2,68,87)(H,69,72)(H,73,84)(H,74,88)(H,75,89)(H,76,92)(H,77,90)(H,78,91)(H,79,94)(H,85,86)/t34-,49+,50+,51+,52+,53+,54+,65+/m1/s1 |
| InChIKey | KDFJEZBQMMRKJX-PTCPGZRVSA-N |
| XLogP | 1.45 |
| TPSA | 404.60 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 95 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1305.37 |
| LogP ≤ 5 | 1.45 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'crown_ether', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166612011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.